secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapsoVision, Inc (CV)
CIK:        0001378325
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001378325-25-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CapsoVision signs $4.1M CMOS sensor development agreement with Canon; overallotment yields $0.6M
--------------------------------------------------------------------------------

- Development agreement with Canon for CMOS image sensor samples; total fee ~$4.1M, $1M cash upfront, remainder via unit price add-on in future purchase agreement.
- Samples to be used for evaluation, clinical evaluation, and FDA 510(k) clearance for future capsule endoscopy products.
- Capso submitted FDA 510(k) for first-generation CapsoCam Colon on June 10, 2025; second generation planned before commercialization.
- Underwriters exercised partial overallotment: 129,978 shares issued for net proceeds ~$600,000; additional warrants for 3,898 shares at $6.25 exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000002/0001378325-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000002/cv-20250715.htm
  HTML page:      https://secwatch.observer/filing/0001378325-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer